Uveitis as an immune-related toxicity during checkpoint inhibitor immunotherapy

被引：0
|
作者：
Ayuso, V. Kalinina [1 ]
Ossewaarde-van Norel, J. [1 ]
Kouwenberg, C. [2 ]
Suijkerbuijk, K. P. M. [3 ]
Kuiper, J. J. W. [1 ]
de Boer, J. H. [1 ]
机构：
[1] UMC Utrecht, Dept Ophthalmol, Utrecht, Netherlands
[2] Jeroen Bosch Ziekenhuis, Dept Ophthalmol, sHertogenbosch, Netherlands
[3] UMC Utrecht Canc Ctr, Dept Med Oncol, Utrecht, Netherlands
来源：
ACTA OPHTHALMOLOGICA | 2019年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [31] Ichthyosis associated with immune checkpoint blockade therapy: A novel cutaneous immune-related toxicity
    Nikolaou, Vasiliki
    Papageorgiou, Chryssoula
    Lazaridou, Elizabeth
    Diamantopoulos, Panagiotis
    Apalla, Zoe
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : 78 - 80
  • [32] Immune Checkpoint Inhibitor Toxicity
    Palmieri, David J.
    Carlino, Matteo S.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [33] Immune Checkpoint Inhibitor Toxicity
    David J. Palmieri
    Matteo S. Carlino
    Current Oncology Reports, 2018, 20
  • [34] Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
    Hamada, Kazuyuki
    Isobe, Junya
    Hattori, Kouya
    Hosonuma, Masahiro
    Baba, Yuta
    Murayama, Masakazu
    Narikawa, Yoichiro
    Toyoda, Hitoshi
    Funayama, Eiji
    Tajima, Kohei
    Shida, Midori
    Hirasawa, Yuya
    Tsurui, Toshiaki
    Ariizumi, Hirotsugu
    Ishiguro, Tomoyuki
    Suzuki, Risako
    Ohkuma, Ryotaro
    Kubota, Yutaro
    Sambe, Takehiko
    Tsuji, Mayumi
    Wada, Satoshi
    Kiuchi, Yuji
    Kobayashi, Shinichi
    Kuramasu, Atsuo
    Horiike, Atsushi
    Kim, Yun-Gi
    Tsunoda, Takuya
    Yoshimura, Kiyoshi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
    Koji Haratani
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    BMC Medicine, 18
  • [36] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge Reply
    Dolladille, Charles
    Da-Silva, Angelique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (11) : 1814 - 1815
  • [37] Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer.
    Ou, Qiyun
    Yu, Yunfang
    Zhong, Haitao
    Li, Anlin
    Chen, Yongjian
    Zhou, Haiyu
    Zheng, Shaopeng
    Huang, Luyu
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Rheumatic Immune-Related Adverse Events-A Consequence of Immune Checkpoint Inhibitor Therapy
    Bobirca, Anca
    Bobirca, Florin
    Ancuta, Ioan
    Florescu, Alesandra
    Padureanu, Vlad
    Florescu, Dan Nicolae
    Padureanu, Rodica
    Florescu, Anca
    Musetescu, Anca Emanuela
    BIOLOGY-BASEL, 2021, 10 (06):
  • [39] Differential risks of immune-related colitis among various immune checkpoint inhibitor regimens
    Yao, Jiannan
    Li, Manyu
    Zhang, Huiyun
    Ge, Yang
    Weygant, Nathaniel
    An, Guangyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 87
  • [40] Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
    Hwang, Sung Wook
    Kim, Min Kyu
    Kweon, Mi-Na
    INTESTINAL RESEARCH, 2023, 21 (04) : 433 - 442
12345